BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neuropharmacology

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2009.01.015PMID 19371576PMCID PMC3659791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine D1 Receptor-induced Signaling through TrkB Receptors in Striatal Neurons*

  2008cited by this paper
• Brain‐derived neurotrophic factor over‐expression in the forebrain ameliorates Huntington’s disease phenotypes in mice

  2008cited by this paper
• Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons.

  2008cited by this paper
• Synaptic activation of dendritic AMPA and NMDA receptors generates transient high-frequency firing in substantia nigra dopamine neurons in vitro.

  2007cited by this paper
• Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior.

  2007influential reference
• Brain-Derived Neurotrophic Factor Restores Synaptic Plasticity in a Knock-In Mouse Model of Huntington's Disease

  2007cited by this paper
• Neurotrophic Factors and Parkinson’s Disease: The Emergence of a New Player?

  2007cited by this paper
• Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism

  2006influential reference
• Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy.

  2006cited by this paper
• Developmental Changes in NMDA Neurotoxicity Reflect Developmental Changes in Subunit Composition of NMDA Receptors

  2006cited by this paper
• A role for Fyn in Trk receptor transactivation by G-protein-coupled receptor signaling.

  2006cited by this paper
• The Influence of Gonadal Hormones on Neuronal Excitability, Seizures, and Epilepsy in the Female

  2006influential reference
• LY503430: pharmacology, pharmacokinetics, and effects in rodent models of Parkinson's disease.

  2006cited by this paper
• Glutamate-based therapeutic approaches: ampakines.

  2006influential reference
• Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease

  2006influential reference
• Positive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Modulators Have Different Impact on Synaptic Transmission in the Thalamus and Hippocampus

  2005cited by this paper
• Prolonged Positive Modulation of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors Induces Calpain-Mediated PSD-95/Dlg/ZO-1 Protein Degradation and AMPA Receptor Down-Regulation in Cultured Hippocampal Slices

  2005cited by this paper
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

  2005cited by this paper
• Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices.

  2005cited by this paper
• Distinct Mechanistic Roles of Calpain and Caspase Activation in Neurodegeneration as Revealed in Mice Overexpressing Their Specific Inhibitors*

  2005cited by this paper
• Memory and addiction: shared neural circuitry and molecular mechanisms.

  2004cited by this paper
• Memory and Addiction: Shared Neural Circuitry and Molecular Mechanisms

  2004cited by this paper
• Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

  2004influential reference
• Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1‐methyl‐4‐phenylpyridinium in nigral slice cultures

  2003influential reference
• LY 503430 , a Novel-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional , Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson ’ s Disease

  2003cited by this paper
• Chronic Elevation of Brain-Derived Neurotrophic Factor by Ampakines

  2003cited by this paper
• Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease

  2003cited by this paper
• Brain-derived neurotrophic factor signal enhances and maintains the expression of AMPA receptor-associated PDZ proteins in developing cortical neurons.

  2003cited by this paper
• LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

  2003influential reference
• LY503430, a Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease

  2003cited by this paper
• Protein degradation in Alzheimer's disease and aging of the brain.

  2002cited by this paper
• Selective reduction of a PDZ protein, SAP‐97, in the prefrontal cortex of patients with chronic schizophrenia

  2002cited by this paper
• Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons.

  2002cited by this paper
• Calcium-dependent Cleavage of Endogenous Wild-type Huntingtin in Primary Cortical Neurons*

  2002cited by this paper
• Activation of Trk neurotrophin receptors in the absence of neurotrophins

  2001cited by this paper
• Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice.

  2001cited by this paper
• Cleavage of Bax is mediated by caspase‐dependent or ‐independent calpain activation in dopaminergic neuronal cells: protective role of Bcl‐2

  2001cited by this paper
• Differential expression of AMPA receptor subunits in dopamine neurons of the rat brain: a double immunocytochemical study.

  2001cited by this paper
• Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra.

  2000cited by this paper
• The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn

  1999cited by this paper
• Enhancement by an ampakine of memory encoding in humans.

  1997cited by this paper
• Stable Expression of Recombinant AMPA Receptor Subunits: Binding Affinities and Effects of Allosteric Modulators

  1997cited by this paper
• Developmental changes in calpain activity, GluR1 receptors and in the effect of kainic acid treatment in rat brain.

  1997cited by this paper
• Dopaminergic stimulation up‐regulates the in vivo expression of brain‐derived neurotrophic factor (BDNF) in the striatum

  1992cited by this paper
• Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

  1992influential reference
• MPTP: current concepts and controversies.

  1986influential reference

• Structural Exploration around 4-Cyclopropyl-Substituted 1,2,4-Benzothiadiazine 1,1-Dioxides: Impact of the Dihalo-Substitution of the Benzene Ring on α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Receptor Potentiation.

  2025cites this paper
• Acute Administration of Ampakine CX1739 after Cervical Spinal Cord Injury.

  2025cites this paper
• AMPA Receptor Modulation in the Treatment of High-Grade Glioma: Translating Good Science into Better Outcomes

  2025cites this paper
• All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants.

  2025cites this paper
• High-Impact AMPAkines Elevate Calcium Levels in Cortical Astrocytes by Mobilizing Endoplasmic Reticular Calcium Stores

  2024cites this paper
• AMPA receptor neurotransmission and therapeutic applications: A comprehensive review of their multifaceted modulation.

  2024cites this paper
• MSK1 is required for the experience- and ampakine-dependent enhancement of spatial reference memory and reversal learning.

  2024cites this paper
• Preclinical Pharmacology of the Low-Impact Ampakine CX717

  2024cites this paper
• Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategy.

  2024cites this paper
• Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763.

  2024cites this paper
• Brain fatty acid and transcriptome profiles of pig fed diets with different levels of soybean oil

  2023cites this paper
• Regulation of AMPAR trafficking in synaptic plasticity by BDNF and the impact of neurodegenerative disease

  2022cites this paper
• Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels.

  2021cites this paper
• Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: a long and winding road.

  2021cites this paper
• The physiology of regulated BDNF release

  2020influential citation
• Modified glutamatergic postsynapse in neurodegenerative disorders.

  2019cites this paper
• Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?

  2019cites this paper
• Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain.

  2018cites this paper
• Neuroprotective effect of olfactory ensheathing cells co‐transfected with Nurr1 and Ngn2 in both in vitro and in vivo models of Parkinson's disease

  2018cites this paper
• Positive Modulation of AMPA Receptors Promotes Survival and Proliferation of Neural Stem/Progenitor Cells from the Adult Rat Spinal Cord

  2017cites this paper
• S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms

  2017cites this paper
• Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats

  2017cites this paper
• Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease

  2017cites this paper
• Influence of a GSK3β phosphorylation site within the proximal C-terminus of Neurofilament-H on neurofilament dynamics

  2017cites this paper
• Hydrogen Sulfide Protects against Chronic Unpredictable Mild Stress-Induced Oxidative Stress in Hippocampus by Upregulation of BDNF-TrkB Pathway

  2016cites this paper
• Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

  2016cites this paper
• Non-canonical Signaling, the Hidden Life of Ligand-Gated Ion Channels.

  2016cites this paper
• Acute ampakine treatment ameliorates age-related deficits in long-term potentiation.

  2016cites this paper
• BDNF-TrkB Pathway Mediates Neuroprotection of Hydrogen Sulfide against Formaldehyde-Induced Toxicity to PC12 Cells

  2015cites this paper
• A role for cell cycle protein E2F1 in HIV-induced neurotoxicity

  2015cites this paper
• Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP+)

  2015cites this paper
• Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo.

  2015cites this paper
• Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.

  2014cites this paper
• A blueprint for research on Shankopathies: A view from research on autism spectrum disorder

  2014influential citation
• Firing Pattern Modulation Through SK Channel Current Increase Underlies Neuronal Survival in an Organotypic Slice Model of Parkinson’s Disease

  2014cites this paper
• Biomarkers for Differential Calpain Activation in Healthy and Diseased Brains: a Systematic Review

  2014cites this paper
• Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases

  2014cites this paper
• Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression.

  2013cites this paper
• Expression of full-length and truncated trkB in human striatum and substantia nigra neurons: implications for Parkinson’s disease

  2013cites this paper
• Distinct Roles for μ-Calpain and m-Calpain in Synaptic NMDAR-Mediated Neuroprotection and Extrasynaptic NMDAR-Mediated Neurodegeneration

  2013cites this paper
• The neuroprotective role of endocannabinoids against chemical‐induced injury and other adverse effects

  2013cites this paper
• Truncated TrkB: beyond a dominant negative receptor.

  2012cites this paper
• Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

  2012cites this paper
• Fragile X syndrome and targeted treatment trials.

  2012cites this paper
• Early diagnosis and therapy of Parkinson’s disease: can disease progression be curbed?

  2012cites this paper
• Chronic inhibition of glycogen synthase kinase-3 protects against rotenone-induced cell death in human neuron-like cells by increasing BDNF secretion.

  2012cites this paper
• A catalytic route to ampakines and their derivatives.

  2011cites this paper
• PI3-K/Akt and ERK pathways activated by VEGF play opposite roles in MPP+-induced neuronal apoptosis.

  2011cites this paper
• ROLE OF CALCIUM IN DEVELOPING CELLULAR NETWORK

  2011cites this paper
• Calpain Plays a Central Role in 1-Methyl-4-phenylpyridinium (MPP(+))-Induced Neurotoxicity in Cerebellar Granule Neurons

  2011cites this paper
• A New Generation Fatty Acid Amide Hydrolase Inhibitor Protects Against Kainate-Induced Excitotoxicity

  2011cites this paper
• Evaluation of the Role of Brain-Derived Neurotrophic Factor in Programmed Cell Death in Hippocampus of Diabetic Rats

  2011cites this paper
• Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone.

  2011cites this paper
• Stem cell technology for neurodegenerative diseases

  2011cites this paper
• Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease.

  2010cites this paper
• Positive Modulation of AMPA Receptors as a Broad-Spectrum Strategy for Treating Neuropsychiatric Disorders

  2010cites this paper
• Adaptive Modifications in the Calpain/Calpastatin System in Brain Cells after Persistent Alteration in Ca2+ Homeostasis*

  2009cites this paper